Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Офтальмология / Английские материалы / Evidence-based Ophthalmology_Wormald, Smeeth, Henshaw_2004.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
6.03 Mб
Скачать

32 Cataract surgical techniques

Jodhbir S Mehta

Background

Cataract surgery forms the major surgical workload of eye departments throughout the world. Technological advances in equipment, as well as intraocular lens design and drugs, have affected the way surgery is being performed, particularly over the past ten years.

Treatment options

Extracapsular extraction with intraocular lens implantation became the panacea in treatment for cataract patients. However, even though spherical equivalent neutrality could be achieved, problems with postoperative astigmatism remained.

Phacoemulsification emerged as an alternative method for cataract removal, through a small incision in a “closed environment”. Although initially viewed with scepticism, almost 90% of cataract surgery is now performed by this technique.

This chapter aims to present evidence available on surgical techniques involved in cataract removal. The randomised controlled trials (RCTs) discussed are concerned with phacoemulsification, including its comparison with extracapsular cataract extraction (ECCE). Studies which looked solely at ECCE surgery have not been included.

Question

What is the difference in effect on surgical outcome between phacoemulsification and extracapsular cataract extraction?

The evidence

There are nine RCTs that have compared the effects of phacoemulsification (phaco) and ECCE (Table 32.1).1–9

There is evidence for significantly greater postoperative inflammation following ECCE than phaco.1–3 Landau and Laurell showed less “in the bag” placement of IOL (intraocular lens implant) haptics following ECCE.4 A better uncorrected visual acuity (UCVA) was shown in patients who underwent phaco compared to ECCE.1,2,5–7 These

studies, however, differ in the length of time in which there is a statistical benefit in UCVA. No statistical difference was noted in endothelial cell loss between the groups, but the coefficient of variation of endothelial cells was higher following ECCE, as was corneal thickness.1,5 Two RCTs have looked at intraocular pressure levels (IOP) after surgery with differing results.8,9 The IOP at six hours post operatively was higher in the ECCE group in Bömer et al.’s

9 ′′

study, and higher in the phaco group in Jurgens et al.’s study.8 Two RCTs showed significantly less posterior capsule opacification following phaco than ECCE.2,7

No statistical difference was shown between the two techniques with respect to progression of diabetic retinopathy or presence of clinical significant macula oedema following surgery,2 or of the cost of the two techniques with respect to the resources used.7

Comment

Overall, the evidence suggests that phacoemulsification has a number of advantages over ECCE; in particular reduced postoperative inflammation, better IOL placement, better UCVA, less posterior capsular opacification and reduced corneal swelling.

Question

What is the effect of different viscoelastics on surgical outcomes?

The evidence

The consequences of using various viscoelastics may be examined by analysing the IOP and endothelial cell function and morphology (Table 32.2). Comparison between studies was difficult since there was incomplete information as to whether patients were given preoperative, intraoperative, or postoperative medication in all cases, which would have had an effect on the postoperative IOP readings.

Three RCTs have compared the use of hydroxypropyl methylcellulose (HPMC) based products with Healon.10–12 Significantly higher IOP was seen in the Healon group at 24 hours in one study.10 However, the other two RCTs showed

221

Notes

 

Results

 

Outcomes

onsurgicaloutcomes

Participants

phacoemulsificationorECCE

Intervention

Effectof

Methods

Table32.1

Authors

Onesurgeon

PostopSTand

guttaesteroids

5eyesECCE

3/7noreadings

LFP/Pachy/VA Nobrownirises

 

 

DCF/flareintensitystatsiglessin

phacogroupat3/7and3/12

=(P0·008),afternoSSD

StatsigbetterUCVAphacogroupat

=3/7(P0·013)butBCVAandcorneal

thicknessnotSSD2groupsatanyFU

 

 

 

 

LFP

ACF

Pachymetry

VA

 

 

Phaco–20eyes

ECCE–20eyes

 

 

 

 

Phaco(5·2mmincision,

scleraltunnel)v

ECCE(11mmincision)

andsutures

PMMAlens

Suturelessphaco

RCT

FU3/7,

3/12,12/12,

24/12

 

 

Laurell

etal.,

1998

 

 

 

 

 

1

 

 

 

Pairedeyes1yr

apart

 

 

 

 

 

2surgeons

gNSAIDpreop,

postopSCand

guttaesteroids

Smallno.

EffectonVA?

 

 

Samesurgeon

gNSAIDpreop

postopSCand

guttaesteroids

 

 

 

 

 

 

 

 

 

 

 

 

 

 

StatsiggreaterSLISinECCEgroup

=1/52FU(P0·0004)

GreaterPCOrateECCEgroup =(P0·01).NoSSDinpresenceof CSME/DRprogressionordevelopof

highriskDRbetweengroups StatsigworseVAinECCEgroupwith

=DRat1yr(P0·01)

CSMEpresentatsurgerymostsig

indicatorofVAat1yrregardlessof surgicalgroup

StatsiggreaterflareandSLISECCE

groupuptoday60(P=0·016)

NoSSDinUCVAat2/12FUboth

groups

Statsighigher“inbag”placementof

=hapticsinphacocases(P0·01) ACdepthstatsigshallowerinECCE

group NoSSDinLFP/ACangle/iristhickness

betweengroups

BCVAstatsigbetterphacothanECCE

<7/7(P0·01)noSSD30/7

NoSSDinECloss.CVstatsighigher

<ECCEgroup(P0·01)

Statsigincreasecornealthickness/EC permeabilityECCEgroupat30/7 <(P0·01)

 

 

 

 

 

 

 

 

Phaco (3·2 mm incision Phaco – 46 eyes LogMar VA

Dowler RCT

CSME

DRprogression

SLIS

PCO

DR)

–46eyes

DR)

 

(12no

ECCE

(15no

 

siliconeIOL)v

ECCE(PMMAlens,

5×10/0nylonstitch)

Diabetics

FU1–2days

1,6wks,

3,9,12,18,

24months

 

2

 

 

etal.,

2000

 

 

LFP

SLIS

VA

 

IOLposition

byUBM

LFP

 

SM

Pachymetry

ACF

VA

ECCE–16eyes

Phaco–18eyes

 

 

Phaco–18eyes

ECCE–17eyes

 

 

Phaco–20eyes

ECCE–20eyes

 

 

Phaco(scleraltunnel,

6mm)vECCE

PigmentedIrides

PMMAlens

Phaco(5·2mmincision,

CCC,scleraltunnel,

sutureless)vECCE

(11mmincision,linear capsulotomy)andsutures PMMAlens

Phaco(5·5mm,

10/0nylon)v

ECCE(10mmlimbal

incision,CCC, 10/0nylon) PMMAlens

RCT

FU1,4,8,15,

30,60,

90days

RCT

FU2yrs

Laurell,

 

RCT

FU7and

30days

 

Chee

etal.,

1999

 

Landau

and

1999

Ravalico

etal.,

1997

 

 

 

3

 

 

 

 

4

 

 

5

 

(Continued)

Notes

Participants Outcomes Results

 

Intervention

(Continued)

Methods

Table32.1

Authors

=0·005)and

phacogroup,

sigbetterUCVA(P

=(P0·044)at1/12

Stat

SIA

 

Keratometry

VA

Phaco–85eyes

ECCE–31eyes

Phaco(Scleralflap,

Superior,2mmpost

RCT

FU3/12

Leen

etal.,

 

 

 

90%power

?initial

 

 

 

noSSDanygroupat3/12

Phacogroupsstatsighigherno.eyes

≤=cyl1·5Dat1/12(P0·05)no SSD3/12

Statsigmoresurgicalcomplications

<=(P0·0001)andPCO(P0·014)

 

 

 

 

 

 

VA

Refraction

 

 

 

ECCE–232eyes

Phaco–244eyes

limbus)vECCE(Limbal

incision,11mm–nuclear

expression)

Phaco(3·2m,OSA,

siliconelens)v

 

 

 

RCT FU3,6/52,3,

1993

 

 

Minassian

etal.,

6

 

 

 

 

investment

 

 

 

 

 

i.c.Ach

Noanti-

glaucomaTx

postop

Smallno.

 

Verysmallno.

Postopanti-

 

 

 

 

 

 

 

 

 

within1yraftersurgeryinECCEgroup,

andpostopastigmatismsigless

frequentinphacogroup.

HigherproportionbetterUCVAof6/9●

<orbetterinphacogroup(P0·0001)

Averagecostsimilarbothgroups.●

StatsighigherIOPphacogroupat●

<6hrs(P0·05),noSSDafter.

StatsighigherIOPinECCEand●

HealonGVthanECCEandHealon

at6hrs

 

IOPhighestat6hrFUbutstatsighigher

=inECCEgroup(P0·016)butnoSSDat

Astigmatism

Complication

rates

PCO

Resourceuse

Costs

IOP

 

 

 

 

 

IOP

 

 

 

 

 

 

 

ECCE–36eyes

(18Healon,18

HealonGV)

Phaco–22eyes

(11Healon,

11HealonGV)

Phaco–108eyes

47Sutureless

ECCE(12–14mm

incision,7mmPMMA

lens,nylonsutures)

 

 

 

ECCE(10·5mmlimbal

incision,PMMAlens,

5×10/0nylonstitch)

vPhaco(3·2mm

incisionsiliconeIOL,

1×10/0nylonstitch)

Phaco(7mm×3·5mm

scleraltunnel)v

6,12months

 

 

 

 

 

RCT

FU3/6/24/

72hrsand

7days

 

 

RCT

FU3/6/24hrs

7

 

 

 

 

 

rgens

etal.,

8

 

 

 

Bömer

etal.,

2001

 

 

 

 

 

Ju

1997

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1995

nylon10/0eyes12–ECCE

extractioncataractextracapsularECCE,implant;lensintraocularIOL,opacification;capsuleposteriorPCO,implant;lensintraocularandphacoemulsificationPhaco,via subjectivescoreinflammatorylampSlitSLIS,photometry;flarelaserLFP,capsulorhexis;curvilinearcontinuousCCC,implant;lensintraocularandexpressionnuclear= subtenons;ST,chamber;anteriorAC,fluorophotometry;chamberanteriorACF,difference;significantstatisticalSSD,barrier;aqueousbloodBAB,flare;andcellsACSC, uncorrectedUCVA,tonometry;GoldmannbymeasurementpressureintraocularIOP,BAB;throughleakagefluoresceinforcoefficientdiffusionmedianDCF,Subconj; %PH,cells;endothelialofvariationofcoefficientCV,microscopy,specularSM,biomicroscopy;ultrasoundUBM,acuity,visualcorrectedbestBCVA,acuity;visual surgicallySIA,astigmatism;ofaxissteepestonincisionOSA,retinopathy;diabeticDR,oedema;macularsignificantclinicallyCSME,cell;endothelialEC,hexagons; astigmatisminduced

glaucomaTx

 

 

24hrs.

 

 

61withsuture

 

 

ECCE(11mmincision)

 

 

9

 

 

 

 

 

Evidence-based Ophthalmology

no difference11,12 but the first had very few patients who underwent phacoemulsification and the second used pneumotonograph for IOP measurements, which could explain the different outcomes. There was a significant increase in corneal thickness at one day postoperatively in an HPMC group compared to Healon but no difference thereafter.12

Four RCTs have compared cohesive with dispersive agents.13–16 No significant difference in IOP at 24 hours postoperatively or endothelial cell dysfunction/loss was seen between Amvisc Plus and Viscoat.13 However, IOP was significantly higher at six hours postoperatively in a Viscoat group compared to Healon 5.14 Miller showed significantly more time was needed to remove Viscoat than Healon GV, but no significant difference was noted in endothelial cell dysfunction between the two groups.15 Koch et al. only showed a significant increase in corneal thickness with

Healon compared with Viscoat at day one postoperatively.16 Three RCTs have looked at different Healon-based derivatives.8,17,18 Higher IOP was seen at six hours with Healon GV compared to Healon in Ju``rgens et al.’s study,8 but no significant difference was seen in Kohnen et al.’s.17 However, in Kohnen et al.’s study preoperative diamox was given. No statistical difference was seen in IOP or corneal thickness postoperatively between patients using Healon or

Microvisc.18

Comment

The evidence suggests that HPMC might produce a lower IOP but more corneal swelling after surgery than Healon. Evidence suggested Viscoat caused raised IOP at 24 hours postoperatively and was more difficult to remove than cohesive agents. Higher viscosity healonoids appear to cause a greater IOP rise at 24 hours.

Question

What is the effect of scleral tunnel depth on surgical outcome?

The evidence

Two RCTs have examined the effect of scleral tunnel depth (Table 32.3).19,20 There was a significantly higher incidence of hyphaema in the deeper scleral tunnel group,19 but no difference was noted in surgically induced astigmatism or wound strength between the two depths.20

Question

What is the effect of a corneal/scleral/limbal located phaco incision on surgical outcome?

The evidence

Four RCTs have compared the effects of scleral tunnel incisions with clear corneal incision,21–24 and four with limbal based incisions25–28 (Table 32.4). In comparing the scleral tunnel incision with the clear corneal (superior or temporal), there was no significant difference in visual acuity between groups postoperatively.21,23,24 There was less alteration in blood aqueous barrier at three days postoperatively and lower IOP at six hours postoperatively with clear corneal incisions than with scleral tunnel incisions.21 Analysis of astigmatism has produced conflicting results with two studies showing less astigmatism,22,23 but Olsen et al. showing greater induced astigmatism in the corneal groups.24 Direct comparison of these studies, however, was not possible since Kurimoto et al.22 looked at absolute postoperative astigmatism,

Cillino et al.23 examined polar values and Olsen et al. examined the changes by vector analysis.

No statistically significant difference was noted in the surgically induced astigmatism between limbal incisions and scleral tunnels after one week.25–27 Gimbel et al.’s study comparing a scleral flap to acute bevelled cataract incision showed greater astigmatism in the latter group, but this may be explained by the effect of sutures rather than location of incision (Table 32.5).26 There was no difference in wound strength between limbal and tunnel groups (whether temporal or superior) after one day.27 There was a lower IOP rise in the tunnel groups at six hours than in limbal, but no difference thereafter.28

Comment

Evidence suggests clear corneal incisions caused reduced inflammation and IOP compared to scleral tunnels. No advantage was seen with respect to the UCVA, and the results were equivocal for astigmatism. Between limbal and scleral tunnels there was no difference in surgically induced astigmatism or wound strength. There was a lower IOP initially in the scleral tunnel group.

Question

What is the effect of incision location on surgical outcome?

The evidence

Studies pertaining to the effect of incision location are tabulated in Table 32.6, all of which examine the effect of location of scleral tunnels.27,29–31 Direct inter-study comparison is difficult since the size of the flaps varies between studies, as does the surgical technique. However, the data suggest a significant reduction in surgically induced

224

Notes

 

Results

 

Outcomes

outcome

Participants

viscoelasticsonsurgical

Intervention

Effectofdifferent

Methods

Table32.2

Authors

 

 

 

Smallno.phaco

group

?Anti-glaucoma

Txpostop

Healonbetter

protectionfor

phaco Singlesurgeon

Anti-glaucoma

Txpostop

Samesurgeon

Achintraop

Noanti-glaucoma

Txpostop

Samesurgeon

30%ViscoatTx

at6hrs

Singlesurgeon

Noanti-glaucoma

Txpostop

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NoSSDIOPat6hrspostopbetween

groups 24hrsIOPstatsighigherHealongroup

=(P0·003)thanAdatocel/AmviscPlus

NoSSDinIOPbetweengroups

NoSSDECClossbetweengroupsor phaco/ECCE

Statsigincreasecornealthicknessat

24hrs

<Adatocelgroup(P0·05),noSSDat

5/52

NoSSDinIOP24hrs–5/52

NoSSDinSM/pachymetrybetween

2groups

NoSSDIOPat24hrs,1/52,8/52

between2groups

IOPstatsig.higherViscoatgroupat

<6hrs(P0·0001),at20hr/24hrand

1/52noSSD

 

 

Statsigmoretimeneededtoremove

<Viscoat(P0·001)

NoSSDincornealthickness,ECCand

meancellsize2groups24hrs,2/52 postop Viscoatbettermaintainingcell

hexagonality

 

 

 

 

 

 

 

 

 

 

 

Adatocel – 50 eyes IOP

vAdatocel

Lüchtenberg RCT

Amvisc Plus –

vPlus Amvisc

24hrsFU

.,al et

 

ECCbySM

50eyes Healon–50eyes Phacoonly

Occucoat–

Healon

Occucoatv

 

RCT

10

and

2000

Smith

IOP

166 eyes

Lindstrom, FU 3/12 Healon

 

Pachymetry

Healon–56eyes Phaco/ECCE andIOL

Adatocel–35eyes

vAdatocel

 

RCT

1991

Pedersen,

11

 

IOP*

 

Healon–35eyes

Phacoonly

Healon

5/52FU

12 1990

Amvisc Plus – IOP

vPlus Amvisc

Probst and RCT

ECC by SM

25 eyes

Nichols, FU 2/12 Viscoat

Viscoat – 25 eyes Pachymetry

13 1993

IOP

Healon

v5 Healon

RCT .,al etRainer

eyes

–35eyes

5–35

Viscoat

Viscoat

1/52FU

14 2000

Healon GV – SM

vGV Healon

Miller and RCT

Pachymetry

70 eyes

Colvard, FU 2/52 Viscoat

OperatingTime

 

Viscoat–70eyes

Phacoonly

15 1999

(Continued)

Notes

Participants Outcomes Results

 

Intervention

(Continued)

Methods

Table32.2

Authors

Singlesurgeon

i.c.Ach

Noanti-glaucoma

Txpostop

 

i.c.Ach.

Noanti-glaucoma

Txpostop

Smallno.

 

 

PreopDiamox

 

 

 

 

 

 

StatsiglesscornealthicknessViscoat

<group1/7(P0·05)notSSD1/52

StatsiglesssuperiorEClossViscoat

<groupat4/12(P0·01) NoSSDinCV/PH,centralECloss2

groupsatanyvisit

StatsighigherIOPHealonGVat6hrs,

<(P0·05),noSSDafter

NoSSDbetweengroupsinptswho

hadIOP>30mmHg

StatsighigherIOPinECCEand

HealonGVthanECCEandHealon at6hrs

NoSSDinIOPmeanin2groupsat

 

 

 

 

 

VA

SM

Pachymetry

 

 

IOP

 

 

 

 

 

IOP

Healon–29eyes

Viscoat–30eyes

Phacoonly

 

 

Healon–37eyes

(Phaco11,

ECCE18)

HealonGV–

37eyes(Phaco11,

ECCE18)

Healon–30eyes

Healonv

Viscoat

Healonv

HealonGV

 

Healonv

RCT FU1/7,1/52, 1,2,4/12

RCT

FU3/6/24/

72hrsand 7days

RCT

al.,

 

rgens

 

 

Kohnen

Kochet

16

etal.,

8

1993

Ju

1997

 

 

 

 

 

 

12hrsbefore.

Noanti-glaucoma

Txpostop

Singlesurgeon.

Singlesurgeon

 

 

alltimesbutSDhigherinHealonGV

at6/24hrsonly

Nodifferencebetween20/40sec

removaltimesforHealonor HealonGV NoSSDinIOPbetween 20/40secgroups

NoSSDinIOP/VAbetween2groups

 

 

Removaltimes

(20secor

40sec)

 

Pachymetry

HealonGV–

30eyes

Phacoonly

 

Healon–49eyes

HealonGV

 

Healonv

FU6/24/36/

48hrsand 1/12

RCT

etal.,

1996

Arshinoff

 

17

 

Ach.

anti-glaucoma

i.c.

No

atanypostopperiod.NoSSDin

cornealthicknessbetween2groups

IOP

VA

Microvisc–51eyes

Phacoonly

Microvisc

 

FU6/24hrs

5/7,1and

and

Hofmann,

1997

op,precomparedgroupsbothhrs24 5/7.atSSDno

methylcellulose;HydroxypropylHPMC,pneumotonograph;bymeasurementpressureintraocularIOP*,tonometry;GoldmannbymeasurementpressureintraocularIOP, ECC,cell;EndothelialEC,hexagons,%PH,variation;ofcoefficientCV,difference;significantstatisticalSSD,deviation;standardSD,microscopy;specularSM, 3%–sulfatechondroitinsodium4%Viscoat,rate);shear0at(cps)centipose4000(viscositysolutionsaltbalancedinHPMC2%Occucoat,count;cellendothelial mosm/kg/H302(osmolality,hyaluronatesodium1%Healon,rate);shear0atcps00040(viscosity1:3)(ratiohyaluronatesodium

mosm/kg/H340(osmolality,hyaluronatesodium1·6%Plus,Amviscrate),shear0atcps0000007(viscosityhyaluronatesodium2·3%5,Healonrate);

mosm/kg/H300(osmolality,lactate-RingerinHPMC2%Adatocel,rate),shear2/sec25°C,atcps00055ofviscosity

rate)shear0atcps0000001(viscosityhyaluronatesodium1%Microvisc,rate);shear0atcps000,0002

Txpostop

 

000200cpsatshear0

2 hyaluronate(viscosity

 

 

 

 

(DynamicO)

 

 

statbutsigincreaseat

 

O)(viscosity

 

HealonO);GV,1·4%sodium

 

 

2

 

 

visits

 

 

 

2

 

atall

 

 

 

 

 

6/12

 

 

 

 

 

18

 

 

 

 

 

 

 

 

 

 

 

Notes

 

Results

 

Outcomes

outcome

Participants

tunneldepthonsurgical

Intervention

Effectofscleral

Methods

Table32.3

Authors

Anticoagulation

stopped

?1surgeon

variationtechnique

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Statsighigherincidenceofhyphaema

<indeepgroup(P0·001)

NoSSDinIOP/VAbetweengroups

 

 

 

NoSSDinSIAbetween2groups(SIA

stabiliseafter4/52in500µmgroup,

1/7in300µmnotSSD)

NoSSDinwoundstrengthbetweenthe

2groups

 

 

 

 

 

 

 

Incidence

hyphaema

VA

IOP

 

 

Woundstrength

byOD

SIA

 

 

Deep–66eyes

Superficial–

63eyes

 

 

 

180eyes

randomised

 

 

 

Phaco,incision

(6mm×3mmpostto

limbus):

Deepscleraltunnel (0·27mm)

v

Superficialpocket (0·17mm) Closedcontinuous suture,10/0nylon

Phacoalleyes,

nosutures:

scleralincision

(trapezoid7mm×1mm

postsurgicallimbus): 300µmv500µm

RCT

FU1/7,4/12

 

 

 

 

RCT FU1/7,

1–4/52,8/12

 

 

al.,

19

 

 

 

 

etal.,

20

 

 

 

Johnet

 

 

 

 

Anders

 

 

 

1992

 

 

 

 

1995

 

 

 

OD, ophthalmodynamometer; SIA, surgically induced astigmatism

Phaco, phacoemulsification and intraocular lens implant; UCVA, uncorrected visual acuity; BCVA, best corrected visual acuity; SSD, statistical significant difference;

Notes

 

Results

 

Outcomes

surgicaloutcome

Participants

orscleralincisionon

Intervention

Effectofcorneal

Methods

Table32.4

Authors

Diclofenacpreop

od

Subconjandg

predpostop

 

 

 

 

 

 

 

 

 

 

 

 

ErrorifuseSIA

notat90°

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AlterationinBABstatsiglowerwith

clearcornealincisioninfirst3/7postop

<(P0·0001).NoSSDat5/12

IOPstatsiglowerCCat6hrs

<(P0·0001),noSSDafter

NoSSDinUCVA/BCVAbetween

2groups

PostopastiglessinCCthaninBENT

<group,onlystatsigat30days(P0·05)

 

 

NoSSDinnetastigbetweengroups

SSDinmeanSIAsinceWRintemporal

groupandARinsuperiorgroup

NoSSDinUCVA(betterVAintemporal

group2/52notSSD)

StatmoreSIA(bothRAandIRA)inCC

<groupupto6/12(P0·01)

NoSSDinVA2groups

 

NoSSDincylinallFUgroups

NoSSDinvector,UCVAbetween

groups

 

 

 

 

 

 

 

 

 

 

 

 

 

FlarebyLFP

IOP

VA

 

 

 

 

Astigmatism

 

 

 

Astigmatism

VA

 

 

 

Astigmatism

CT

VA

 

Astigmatism

UCVA

 

CC–50eyes

SC–50eyes

AllCaucasian

 

 

 

 

CC–29eyes

BENT–29eyes

 

 

Temporal–40eyes

Superior–40eyes

 

 

 

CC–50eyes

SC–50eyes

 

 

Limbal–21eyes

Tunnel–23eyes

 

Temporalincision:

Clearcorneal(CC)

(3·2mm)v scleraltunnel(SC)

(1·5mmpostlimbus,

3·2mm)

PhacoandsiliconeIOL

Phaco:

Clearcorneal(CC)

(4·1mm)OSAv

BENTscleraltunnel (1·5mmpostlimbusx 4·1mm)

Phaco,nostitch:

Temporal(corneal,

5·2mmincision)v

Superior(linear,5×1mm

posttolimbus) PMMAlensbothgroups

Phaco:

Clearcorneal(CC)

v

Scleraltunnel(SC) (2mmpostlimbus) Incisions3·5–4mm length,OSA

Phaco,superior: scleraltunnel(5mm×

2mmpostlimbus,frown incision,1stitch)v limbalincision(5mm, continuousXsuture)

RCT

FU6hrs,1/7,

2/7,3/7and

5/12

 

 

 

RCT FU1,3,10,30

and100days

 

RCT FU1/7,2and

8/52

 

 

RCT

FU1/7,1/52,

6/12

 

RCT FU1/7,2/52,

1,3,6months

Dicketal.,

2000

 

 

 

 

 

Kurimoto

etal.,

1999

 

Cillinoetal.,

1997

 

 

 

Olsenetal.,

1997

 

 

Hunoldetal.,

1995

 

 

21

 

 

 

 

 

 

 

22

 

 

23

 

 

 

 

24

 

 

 

25

 

(Continued)

Notes

Participants Outcomes Results

 

Intervention

(Continued)

Methods

Table32.4

Authors

Statsigincreaseinkeratometriccyl

=ingp2(P0·005),noSSDgp1

comparedwithpreoplevelsat2/12

NoSSDat1yrbetweengroups

NoSSDinSIAupto1yrpostop,butno. ofeyeswithinducedATRcylstatsig

higherthannumberwithWRforboth

<groups(P0·1)

=StatsiggreaterSIAat1/7(P0·005)

inlimbalgroupthanscleral,noSSD

afterinsuperiorgroup

Statsiggreaterwoundstrength1/7FU =scleralincision(P0·001)butnoSSD

after,insuperiorgroup

StatsiggreaterSIAinlimbalgroupthan

<scleralat1/52(P0·001)butnotSSD

after,intemporalgroup

NoSSDwoundstrengthbetween

2groups

 

 

 

 

 

 

 

 

 

 

Astigmatism

 

 

 

 

 

 

Woundstrength

byOD

SIA

 

 

 

 

 

 

 

Acutebevelled

incision–28eyes

Horizontalsuture–

35eyes

 

 

 

180eyes

randomised

 

 

 

 

 

 

 

 

Phaco,superior:

Scleralflap(6mm×

2·5mmfrownincision,

horizontalsuturegp1)

v acutebeveledincision

(ABI,6mmincision,

limbal,gp2,running suture) Suture10/0prolene AllWRastigpreop

Phaco,superior,no

sutures:

limbalincision(7mm,

trapezoid)v scleralincision

(trapezoid7mm×1mm

postsurgicallimbus)

Phaco,temporal,no

sutures:

Limbalincision(7mm,

trapezoid)v

RCT

FU2days,

2wks,6and

12months

 

 

 

RCT FU1/7,

1–4/52,8/12

 

 

 

 

 

 

 

al.,

 

 

 

 

 

 

al.,

 

 

 

 

 

 

 

 

 

et

26

 

 

 

 

 

et

27

 

 

 

 

 

 

 

 

Gimbel

 

 

 

 

 

Anders

 

 

 

 

 

 

 

 

1995

 

 

 

 

 

1997

 

 

 

 

 

 

 

 

 

7different

surgeons occpiloatend

 

 

 

lowerIOPfortunnelgroupat

=0·0009),noSSDafter

moreIOP>30insuturegroup,

 

Statsig

6hrs(P

Statsig

 

 

 

IOP

 

 

 

Limbal–56eyes

Tunnel–44eyes

 

Scleralincision (trapezoid7mm×1mm postsurgicallimbus)

Phacosuperiorincision

i.c.Achincision:

7mmlimbal(5×10/0

 

RCT

FU3,6,

23hrs

 

al.,

 

 

 

et

28

 

 

Bömer

1995

 

over FU

vnylon)

 

Goldmanntonometry;UCVA,

surgicallyinducedastigmatism;

 

scleraltunnel(7mm× 2mmscleralflap, nosutures)

LFP,laserflarephotometry;BAB,bloodaqueousbarrier;SSD,statisticalsignificantdifference;IOP,intraocularpressuremeasurementby

uncorrectedvisualacuity;BCVA,bestcorrectedvisualacuity;CT,cornealtopography;OSA,incisiononsteepestaxisofastigmatism;SIA,

RA,regularastigmatism;IRA,irregularastigmatism;BENT,betweennineandtwelveo’clock;OD,ophthalmodynamometer

Notes

 

Results

 

Outcomes

 

Participants

sizeonpostoperativeoutcome

Intervention

Effectofincision

Methods

Table32.5

Authors

<3·5mmlessearlySIA(P0·02)and <morerapidVArehab(P0·05). 5·5/6mmmoreearlytotal keratometriccylandSIA.

NoSSDinSIAamong3groups at3/12 EarlierVArecoveryin4/5·2mm groups 4mmstatsigbetterUCVAat3/12

 

 

Astigmatism

VA

 

151eyes

 

 

flap2·5mmpostlimbus:

v5·5mmv

 

Scleral 3·5mm

6·5mm

RCT

FU2/12

 

Maghraby-El

etal.,

1993

 

 

32

Astigmatism

VA

 

4mm–280eyes

5·2mm–215eyes

7mm–20eyes

flap2mmpostsurgical

limbus:

5·2mmv7mm

Scleral

4mmv

RCT

FU3/12

 

al.,

 

 

et

1991

 

Grabow

 

 

33

 

 

Differentlenses

PCOrates

Nosuture

removedduring

study

Differentlenses

 

 

 

3groupsnoSSDinSIA <UCVAonlySSD(P0·01)2/7later noSSD

3·2mmgroupstatsigreducedSIA

<andbetterUCVA(P0·001).BCVA equal2groups.WWstatsig commonerin3·2mmgroup

4mmstatsigbetterUCVAandSIAat

1/12,noSSDanygroupat3/12

 

=3·5mmlessSIA(P0·046),better <UCVA(P0·01)at3/12,afterwards noSSDbetweengroups

Keratometry

VA

Keratometry

VA

3·2mm–68eyes

5mm–60eyes 6mm–68eyes

3·2mm–55eyes

5·5mm–56eyes

Scleralflap,3mmpostlimbus:

3·2mmv5mmv6mm

Scleralflap,superior,1·5mmpost

tolimbus: 3·2mmv5·5mm

RCT

FU6/12

RCT

FU36/12

al.,

 

al.,

 

et

34

et

35

Martin

1993

Olson

1998

Keratometry

VA

 

Keratometry

VA

4mm–26eyes

6mm–59eyes

11mm–31eyes

3·5mm–40eyes

5·1mm–40eyes

Scleralflap,superior,2mmpost

limbus:4mm,6mm

Limbalincision:11mm–nuclear expression 10/0nylonsuturesradial4mm (1),6mm(2),11mm(6–9)

Scleralflap,superior,3mmpost

tolimbus: 3·5mmv5·1mm

RCT

FU3/12

 

RCT

FU6/12

al.,

 

 

al.,

 

Leenet

6

 

Levyet

36

1993

 

1994

NoSSDinUCVA,SIA2groups

 

 

Keratometry

VA

–58eyes

59eyes

3·2mm

4mm–

Scleralflap,superior,

3mmposttosurgicallimbus:

RCT

FU6/12

Mendivil,

1996

 

37

mm4·0

vmm 3·2

1 × 10/0 nylon radial suture all cases

SIAandnetpostopastigmatismnot

SSDbetween2groups

 

SIA

 

90eyes

110eyes

6·5mm–

7·5mm–

Scleralflap,superior:6·5mm

v7·5mm

RCT

FU1/7,2–3

al.,

 

et

38

Gimbel

1992

differentsuture

suturedcontinuous

Phaco,4

material,

wks,2/3/6/

12/24months

(Continued)

Notes

Participants Outcomes Results

 

Intervention

(Continued)

Methods

Table32.5

Authors

Onesurgeon

Onesurgeon

 

 

 

 

 

 

NSAIDonly

postop

 

 

 

 

 

 

 

SSDSIAbetween2groupsat4/12 <(P0·01).6mminducedsigmore casesofARatanearliertimethan <the4mmgroup(P0·02).

At2/52noSSDinmeanSIAbetween groups.WRshiftsseeninboth groups.NoSSDinmeanSIAat1yr betweengroups.ARshiftsseenin bothgroups.NoSSDinUCVAbetween 2groups.Statsighigherincidence 1/7hyphaemain5·5mmgroup

<3·2mmstatsig(P0·01)betterUCVA

1/12postopnoSSDafterin2 groups SIAless3·2mmthan5mmupto

6/12(overallsmall).3·2mmstat ≤sigmoreptscyl1·5Dat1/12 <(P0·05).3·2mmstatsiglessWRFon <CT(P0·01).Aqflare/cellstatsigless <3·2mmat1/52(P0·05),afterno SSD.NoSSDFP,SMat3/12

SIAlesswith3·2mm.3·2mmno

changecentralcornea,4/5mmfocal steepening 3·2mmcornealshaperecoverby

1/12,4/5mmnotfullyrecover6/12

NoSSDinBABdisruptionbetween

2groups

 

 

 

SIA

 

 

 

Astigmatism

UCVA

Hyphaema

 

Keratometry

VA

CT Aqueousflare SM FP

98eyes

99eyes

 

 

93eyes

–98eyes

 

 

–93eyes

–89eyes

 

4mm–

6mm–

 

 

4mm–

5·5mm

 

 

3·2mm

5·5mm

 

Scleraltunnel,superior,2mm

postlimbus:

4mm(110/0nylonsuture)v

6mm(2X10/0nylonsuture) Nosuturesremoved

Scleraltunnel,superiorlinear

groove3mmposttolimbus:

4mm(foldedsiliconelens)v

5·5mm(PMMAlens) 2×pattern10/0nylonfor allcases NosuturescutduringFU

Scleralflap,superior,2·5mm

postsurgicallimbus:

3·2mmv5·5mm

RCT

FU1/7,

1,2/52

1,4/12

RCT FU1/7,2/52,

1yr

 

RCT

FU6/12

 

Dam-Johansen

Olsen,and

1997

 

Davison,

1993

 

 

Oshikaetal.,

1994

 

 

 

39

 

 

40

 

 

 

41

 

CT

Scleral flap, BENT, 2 mm post 200 eyes:

RCT .,al etHayashi

Keratometry

 

 

–64eyes

65eyes

71eyes

3·2mm

4mm–

5mm–

ant.marginlimbalarcade:

3·2mmv4mmv5mm

 

FU6/12

 

 

42

 

 

1995

 

 

FP

VA

3mm–20eyes

6mm–19eyes

flap,superior:

6mm

Scleral

3mmv

RCT

FU5/7

Diestelhorst

43

etal.,1996

(Continued)

Notes

Participants Outcomes Results

 

Intervention

(Continued)

Methods

Table32.5

Authors

 

 

 

Onesurgeon

 

 

 

 

 

 

 

SIAstatsiglowerin3·5mmthan

<4/5mm(P0·05)at6/12.Temporal

incisionminimalSIAover6/12

NoSSDinPH/CVbetween2groups

atFU

MeanECloss3·5mmlessthan5·0mm

 

 

 

Keratometry

CT

 

EClossbySM

 

 

–20eyes

20eyes

20eyes

–28eyes

30eyes

 

3·5mm

4mm–

5mm–

3·5mm

5mm–

 

Cornealincision,temporal2step:

3·5mmv4mmv5mm(1radial

suture10/0nylon)

Clearcornealincision,temporal

2step:

3·5mm(suturelessandinjector

RCT

FU6/12

 

RCT

FU4/7,6,

12months

al.,

1995

 

Dicketal.,

1996

 

Kohnenet

 

 

 

44

 

 

45

 

at 1 yr but not stat sig

vlens) siliconefoldable

siliconemm

3·5 ●

No inSSD changesCT/ECC

 

CT

 

3·5mm–100eyes

(radialsuture,PMMAlens)

cornealtemporalincision:

5mm

Clear

Holweger and RCT

5 PMMAmm

● (smallest8/12

between atgroups

5 mm – 100 eyes ECC

mm5

v(sutureless) mm3·5

8/12FU

Marefat,

 

IOLcentrationbetweengroups

againsttherule

1997

BCVA,acuity;visualuncorrectedUCVA,astigmatism;inducedsurgicallySIA,bestcorrectedvisualacuity;BENT,betweennineandtwelveo’clock;AR, astigmatism;woundthewithWW,astigmatism;rulethewithWR,astigmatism;WRF,woundrelatedflattening;SSD,statisticalsignificantdifference; BAB,Fluorophotometry;FP,microscopy;specularSM,topography;cornealCT, bloodaqueousbarrier;D&C,divideandconquer;EC,endothelialcell; cells;endothelialofvariationofcoefficientCV,count;cellendothelialECC,PH,%hexagonalendothelialcells

in diff No . group) mm 3·5 cyl change

 

 

centrationIOL

 

 

(1suture10/0vicryl)

 

 

46

 

 

 

 

 

Cataract surgical techniques

astigmatism in the temporal and BENT (BEtween Nine and Twelve o’clock) location compared to superior incisions.27,29,30 However, no difference was noted in visual acuity.29,30 One study examined wound strength and found no significant difference between temporal or superior scleral flaps.27

The evidence suggests reduced surgically induced astigmatism in the temporal and BENT groups compared to superior incisions but no difference in wound strength or visual acuity.

Question

What is the effect of phaco incision size on surgical outcomes?

The evidence

Thirteen RCTs have examined the effect of the different size of scleral flaps6,32–43 while three have concentrated on clear corneal incisions (Table 32.5).44–46 Inter-study comparison of the scleral flap groups are problematic since apart from the variation in sizes of incision studied, the use of sutures and their tightness will have an effect on astigmatic outcome measures. However, evidence from the studies suggested that smaller incisions were associated with statistically less surgically induced astigmatism and an earlier rehabilitation in visual acuity, particularly uncorrected visual acuity.6,32–41

Further outcome measures in patients who had variation in the size of their scleral tunnels included a higher incidence of hyphaemas in larger incision group,40 significantly lower aqueous humour cell count and flare at one week postoperatively,41 less wound-related flattening at three months,41 and fewer central corneal changes on corneal topography in the smaller incision group.42 No statistical difference was noted with respect to specular microscopy or fluorophotometry between different incision sizes.41,43

For corneal incisions the influence of incision size on outcome appears to be similar to scleral tunnels. There was significantly less astigmatism in the smaller incision group after six months.44 There was no statistical difference in endothelial cell morphology or endothelial cell loss,45,46 or corneal topography changes between incision sizes studied.46

Comment

Overall, the evidence suggests that smaller scleral tunnel incisions were associated with less astigmatism, improved earlier UCVA, reduced incidence of hyphaemas, less

postoperative inflammation, less wound-related flattening, and less change in the central cornea on corneal topography compared to large incisions. Smaller corneal incisions were also associated with reduced astigmatism compared to larger ones.

Question

What is the effect of different phacoemulsification techniques on surgical outcome?

The evidence

Four studies have looked at different techniques for nuclear fractis (Table 32.7).16,47–49 Less corneal endothelial cell loss was shown to occur when performing phaco in the posterior chamber as opposed to iris plane.16 A comparison of divide and conquer to three other techniques, showed less endothelial cell loss at one month compared to Chip and Flip but this was not significant at three months.47 “Reversed Tip and Snip” showed significantly less endothelial cell loss compared with divide and conquer at three months.48 “Phaco chop” showed significantly less phaco time, less phaco power and less equivalent phaco time in comparison to divide and conquer.49 However, there was no difference between the two groups with respect to complications or postoperative visual acuity.

Comment

The evidence suggests that endocapsular phaco surgery is safer than iris plane, and that there are advantages of the newer nuclear fractis techniques.

Question

What is the effect of sutures on phaco incision closure?

The evidence

Table 32.8 summarises RCTs on the effect of sutures on phaco incision closure, which have looked at scleral tunnels (Table 32.8).25,28,26,39,50–55 Intraoperative variations, such as linear versus frown incision, amount of cautery and size of incision (4–7 mm), make it difficult to compare the studies directly using the size of postoperative astigmatism as a outcome measure.

In comparing studies that examined the effect of no suture v one suture (in all cases 10/0 nylon, eight studies),25,28,39,50–54 only one study showed any difference between the two groups with respect to the amount of

233

Notes

 

Results

 

Outcomes

outcome.

Participants

locationonsurgical

Intervention

Effectofincision

Methods

Table32.6

Authors

 

 

 

 

 

 

 

 

 

 

Nodetailsonno.

 

 

 

 

 

 

 

=SIAlessBENTthansuperior(P0·001)

at1/52,notSSD24/52

UCVAstatsigbetter1/52,notSSD

24/52

ReducedSIAinmodifiedBENT

=(P0·0001)

SuperiorgrouplargestSIA

NodifferenceUCVA

SIAsuperiorgroupassoc.AR

SIAlateralgroupassoc.WR

NoSSDinlimbalincisionssupv temp,upto4/52.StatsiglessSIAin

temporalthansupat8/12scleral

=group(P0·001). SIAhighestwithsuperiorlimbal

incisionsat8/12

NoSSDinscleralincisionwithregard

towoundstrength Statsigstrongerwoundtemporallimbal

=thansuperiorat1/52(P0·003)

 

 

 

 

 

 

 

Astigmatism

VA

 

 

Astigmatism

VA

 

Astigmatism

VA

CT

Woundstrength

byOD

SIA

 

 

 

 

 

BENT–121eyes

Superior–59eyes

 

 

63eyes

 

 

168eyes

randomised

 

180eyes

randomised

 

 

 

 

 

 

Scleralpocket,6·5×

2mm:

BENTv

Superior

Scleralpocket,7×2mm:

superiorv temporalv modifiedBENT

Scleralpocket,4×3mm;

superiorv lateral

Scleral(trapezoid)

incision(7mm×1mm

postsurgicallimbus):

Superiorv temporal

limbalincision

(trapezoid)(7mm):

superiorv temporal

Nosutures

CCT

Phacoand

6mmlens

FU24/52

RCT

FU5/12

Phacoand PMMAlens

RCT

Phacoand

5mmlens FU6/12

RCT

FU1/7,

1–4/52,8/12

 

 

 

 

 

Kawano

etal.,

1993

 

Wirbelauer

etal.,

1997

Mendivil,

1996

 

Andersetal.,

1997

 

 

 

 

 

 

 

 

29

 

 

 

30

 

31

 

 

27

 

 

 

 

 

 

betweennineandtwelveo’clock;UCVA,uncorrectedvisualacuity;AR,againsttheruleastigmatism;WR,withtherule

CT,cornealtopography

SIA,surgicallyinducedastigmatism;BENT,

astigmatism;OD,ophthalmodynamometer;

Notes

 

Results

 

Outcomes

surgicaloutcome

Participants

Effectofphacoemulsificationtechniqueon

Methods Intervention

Table32.7

Authors

Singlesurgeon●

i.c.Ach.●

Noanti-●

glaucomaTx

postop

Smallno.

 

 

CentralEClossstatsiggreaterinIP

<groupat4/12(P0·12)

ReducedincreaseinCV/PHcentrallyin

<PCgroup(P0·02).

 

GreaterEClossC&Fgroupat1/12

=(P0·05),notsig3/12 IncreasecellshapevariationC&Fgroup =(P0·03) NoSSDincornealthicknessanyFU

ReverseTip&Sniplesscelllossthan <D&C(P0·001)

 

VA

SM

Pachymetry

IP−26eyes

PC–33eyes

 

Irisplane(IP)phaco

v

C&FPhaco(PC)

RCT FU1/7,1/52,

1,2,4/12

al.,

 

 

et

16

 

Koch

1993

 

ECC

Corneal thickness

ECC

 

D&C–22eyes

C&F–19eyes

30eyeseachgroup

 

D&Cv

C&F

D&Cv

ReverseTip&Snip

RCT

FU3/12

RCT

FU3/12

Kosrirukvongs

etal.,1997

Kohlhaas

etal,1997

 

47

 

48

Phaco lessChop timephaco

● time/Phaco

–D&C eyes55

vChop Phaco

RCT

.,al etWong

<<powerD&CPhacoChop–(P0·0001),EPT(P0·0001) Equivalent62eyesNodiffcomplications●

phacotimePhacoChopshorteroperatingtime●

VA Intraop complications Operatingtime

flip;EPT,equivalentphacotime;EC,endothelialcell;ECC,endothelialcellcount;SM,specularmicroscopy;

 

 

 

 

cells;PH,%hexagons

2000

 

 

anddivideD&C,conquer;C&F,chipand

coefficientCV,ofvariationofendothelial

2/52FU

 

 

 

 

49

 

 

 

 

 

 

 

 

 

Evidence-based Ophthalmology

surgically induced astigmatism, which was significant at one week postoperative but not at three months.50 However, three studies showed earlier stabilisation of astigmatism in the sutureless incision group.41,51,52 Analysis of surgical outcomes for which there was no statistical difference included computerised videokeratography,53 uncorrected visual acuity,25 and intraocular pressure.28

One study looked at the effect of suture adjustment intraoperatively, and suggested less variation in postoperative astigmatism between the adjusted and unadjusted groups up to two years but this was not statistically significant.54

Azar et al. compared sutureless incisions to closure with one and three sutures.55 They suggested that one stitch closure in a 5·5 mm scleral flap incision was the most astigmatic neutral closure.55 Gimbel et al. compared sutureless closure with three different suture closures and suggested that horizontal suture closure of a 6 mm flap was the most astigmatic neutral closure.26

Comment

Overall, the evidence suggests a minimal difference in induced astigmatism between sutureless and one suture groups, but earlier stablisation of astigmatism in the sutureless group.

Question

What is the effect of different suture material or technique on incision closure?

The evidence

Three RCTs have examined the effect of different suture materials on incision closure38,56,57 and one has examined different techniques of suture tying (Table 32.9).46 Two studies have looked at scleral tunnel incisions,38,56 one at clear corneal incisions46 and one is an objective comparison in a mixture of cases of phaco, ECCE, and intracapsular cataract extractions.57 Mersilene, 9/0 and 10/0 nylon induced statistically more with the rule astigmatism than Prolene and Novafil at day one.38,56 However, by two months there was no statistical difference in the astigmatism or UCVA between the groups.38

Following clear corneal incisions, no statistical difference in corneal topography was noted between one radial suture and one X suture after eight months.48

Comment

Mersilene, 9/0 and 10/0 nylon induced more astigmatism than Prolene and Novafil in the short term. No topographical difference was seen between one radial suture or X suture in incision closure.

Question

What alternatives are there to sutures for incision closure?

The evidence

Table 32.10 tabulates RCTs investigating the effect of incision closure by alternative materials.50,58–60 Three studies compare the effect of scleral tunnel closure with a tissue adhesive (fibrin in two studies, cyanoacrylate in one) to closure with one suture. Cyanoacrylate was shown to be safe and equally as effective as suturing with respect to postoperative astigmatism.50 Both the fibrin studies showed that fibrin was safe and induced significantly less postoperative astigmatism than a single suture. However, no difference was noted in final best-corrected visual acuity between the fibrin group and sutured group.58,59 There was no discussion about the costs of these materials.

One study examined conjunctival closure either manually or after saline injection. Subjective evidence suggested better closure with saline injection after one week but no difference after one month.60

Comment

The evidence suggests adhesive closure is equal to or better than single suture closure with respect to postoperative astigmatism.

Summary

These studies have provided evidence for the benefits of sutureless or single suture closure, small astigmatic neutral incisions, and temporal clear corneal incisions. The evidence from specific surgical techniques along with evidence from Table 32.1 indicates the advantages of phacoemulsification over ECCE. Viscoelastic technology has also improved to enhance the effectiveness of endothelial protection during phacoemulsification. However, only one randomised controlled trial examined the cost-effectiveness of the two procedures. In developing countries where phacoemulsification is now being performed in major cities, the initial investment needed to buy equipment may well put phaco out of the reach of the masses of the rural population who are “blinded” with cataracts. However, distinct advantages such as the reduced rate of posterior capsular opacification, fewer surgical complications, and better UCVA, may well make the initial investment financially viable in the long term.

236

Notes

 

Results

 

Outcomes

 

Participants

onphacoincisionclosure

Intervention

Effectofsutures

Methods

Table32.8

Authors

Onesurgeon

Onesurgeon

 

Nocuttingof

sutures

Onesurgeon

Onesurgeon

 

 

 

 

Statsigmoreastigmatismin <suturelessgroup(P0·01)at1/52, noSSDat12/52

NoSSDinSIAbetweenbothgroups butsinglestitchhadlargerinduced cyl. InitialWRshift,insuturegroupat 1/52thenfollowedastigmatismof suturelessgroupbutnotSSD

NoSSDinUCVAbetweengroupsall FUvisits.ARpresentinbotheyes postopbutnoSSDbetweengroups anyFUvisit SIAstabilisedquickerinsutureless group,notSSD

NoSSDinpostopcylbetween

3groups

NoSSDinSIAat3/12between groupsbutsuturelessreachvalue 1/52andstableafter Suturedstatsigchange1/52–3/12 <(P0·01) Mostvariationunadjgroupthough notSSD

NoSSDincomplications/AR betweengroups.Flatteningalong90° meridianmorewithoutsuturebutnot SSD NoSSDinmeancornealpowerat 90°meridian

NoSSDincylinallFUgroups NoSSDinvector,UCVAbetween groups

Astigmatism

 

 

SIA

 

 

 

Suture–105eyes

Sutureless–

101eyes

Suture–49eyes

Sutureless–

49eyes

 

Superior,6·5mm×2·5mm

behindlimbus,frownincision

scleraltunnel: ×closurewithsuture(110/0 nylon,horizontalanchor)v sutureless

Scleraltunnel,superior,2mm

postlimbus:

4mm(110/0nylonsuture)v

4mm(sutureless).Nosutures removed

RCT

FU1,12/52

 

RCT

FU1/7,

1,2/52

1,4/12

Alióetal.,

1996

 

Dam-Johansen

andOlsen,

1997

 

 

50

 

 

 

39

 

Astigmatism

UCVA

 

Suture–58eyes

Sutureless–

48eyes

Superior,3·2mmx3mmpost

surgicallimbus,linearincision

scleraltunnel: ×closurewithsuture(110/0 nylon,radial)vsutureless

RCT FU1,2wks,

1,3,6months

Mendivil,

1997

 

 

51

 

Superior, 5·2 mm × 2 mm behind Adj suture – Astigmatism

Lyhne and RCT

Size

Corydon, FU 1/52 1, 3 limbus, linear incision scleral 25 eyes

SIA

Timefor

stability

 

Unadjsuture–

24eyes

Sutureless–

26eyes

 

cyl.1DWR

×unadjusted

10/0nylon)

tunnel:

Adjusted(intraop

CrossSuture)v1

crosssuturev nosuture(suture

and6/12

 

 

 

52

 

 

 

1996

 

 

 

CVK

SIA

 

Astigmatism

UCVA

 

Suture–15eyes

Sutureless–

15eyes

1stitch–

23eyes

Sutureless– 23eyes

Superior,6mm×2mmbehind

 

 

×

 

 

limbus,frownincisionscleral

tunnel: ×Closurewithsuture(110/0 nylon,horizontalmattress)v sutureless

Superior,scleraltunnel(5mm

2mmpostlimbus,frown

incision): 1stitchvsutureless

RCT

FU6/52

 

RCT

FU1/7,2/52,

1,3,6months

al.,

 

 

al.,

 

 

et

1995

 

1995

 

KasabyEl

 

Hunoldet

 

 

53

 

 

25

 

(Continued)

Notes

Participants Outcomes Results

 

Intervention

(Continued)

Methods

Table32.8

Authors

Multiplesurgeons

 

 

Nocuttingof

sutures

Onesurgeon

 

 

 

Twosurgeons

PMMAlens

 

 

 

 

 

 

IOPhighestat6hrsbutnoSSD

betweengroups

 

NoSSDinpostopcyl(6/12–

24/12)betweengroupsbutmore

fluctuationinunadjgroup.NoSSDin

SIAat2yrFU,butunadjgroup

furtherARdriftbetween1–2yrs,

othergroupsstable(adj6/12, sutureless1/52)

StatsigbetterUCVAinnoand

1suturegroupthan3suturesat

 

 

 

 

 

 

 

 

IOP

 

 

Astigmatism

Size

SIA

 

 

 

SIA

VA

Suture–61eyes

Sutureless–

47eyes

Adjsuture–

25eyes

Unadjsuture–

24eyes

Sutureless–

26eyes

Sutureless–

50eyes

Superior,7mm×3·5mmscleral

tunnel:

×Suture(110/0nylon)v sutureless

Superior,5·2mm×2mmpost

limbus,linearincisionscleral

tunnel:

Adjusted(intraopcyl.1DWR

crosssuture)versus1×

unadjustedcrosssuturev sutureless(suture10/0nylon)

Superior,5·5mm×1·5mmpost

surgicallimbus,scleraltunnel:

RCT

FU3/6/24hrs

 

RCT

FU6/12,1,

2yrs

 

 

 

RCT FU1/7,1,4,

Bömeretal.,

1995

 

Lyhneand

Corydon,

1998

 

 

 

Azaretal.,

1997

 

28

 

 

 

54

 

 

 

 

55

suturesNo

1/52 no SSD after

1 suture –

vsutureless

8 6,wks,

cut.1suture

lowest%WR

(4/52)and

withoutsig

ARshift

Onesurgeon

 

 

 

 

 

NoSSDinsurgicallyinducedSphEq

atallvisits

Meankeratometricastigstatsig

=greater3sutures(P0·07)postop,

noSSD8/52 StatsighigherARshiftinsutureless groupandsigWRin3suturesgroup <8/52postop(P0·05)noSSDafter

Statsigreductioninkeratometriccyl

 

 

 

 

 

 

 

Astigmatism

40eyes

3sutures–

41eyes

 

 

Sutureless–

1suture(radial)v

3sutures(radial) (suture=10/0nylon)

Superiorscleraltunnel:

12months

 

RCT

 

 

al.,

 

 

Gimbelet

 

==2wks,6andHorizontalfrownincision,gp1)versus3(P0·020)and4(P0·005),no

12monthssuture–35eyes2.Horizontalsuture(6mmx2·5mmSSDgroup2withpreoplevels.No Horizontalandfrownincision,gp2)versusSSDat1yrbetweengroups running–31eyes3.Horizontalandrunning(HR)NoSSDinSIAupto1yrpostop,but●

Acutebeveledsuture(6mmx2·5mmfrownno.ofeyeswithinducedATRcylstat incision–28eyesincision,gp3)versussighigherthannumberwithWRfor <4.Acutebeveledincision(ABI,all4groups(P0·01) 6mmincisionlimbal,running suture,gp4)(suture10/0Prolene)

preopastigWRAll

difference,

1995

uncorrectedUCVA,implant;lensintraocularandphacoemulsificationPhaco,visualacuity;BCVA,bestcorrectedvisualacuity;SSD,statisticalsignificant WR,astigmatism;ruletheagainstAR,videokeratography;computerisedCVK,withtheruleastigmatism;Cyl,cylinder;EC,endothelialcell; microscopy;specularSM,topography;cornealCT,count;cellendothelialECC,vicryl,polglactin;SphEq,sphericalequivalent

gp in increased sig stat 2/12, at gp1

 

 

 

 

 

eyes34

 

 

 

 

 

1.Sutureless(6mmx2·5mm

 

 

 

 

 

 

 

 

 

 

FU2days,

 

 

 

 

 

26

 

 

 

 

 

 

 

 

 

 

 

Notes

 

Results

 

Outcomes

 

Participants

suturevariationonincisionclosure

Intervention

Effectof

Methods

Table32.9

Authors

Samesurgeon

Suturesnotcut

IOPequalafter

suturewith

Schiotz

Differentknot

tying

 

 

 

 

Samesurgeon

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NoSSDinUCVAbetweengroups

postop SSDbetweengroupsinmeanpostop

astigmatism

ARwith10/0andWRwith9/0inall <FUvisits(P0·05)

NoSSDinUCVAamonggroupsany

FUvisit.At1/7nylonandMersilene

statsigmoreWRandSIAthan <Prolene/Novafil(P0·01) WRdecayedfasterfor >nylonMersileneover3/12.At2/12

noSSDbetweengroups ARshiftseeninProlene(1/12),

Novafil(2/12),Nylon(5/12), Mersilene(8/12) DecaystableProlene(5/12),Novafil

andMersilene1yrbutNylonsigAR shiftbetween1–2yrs

Monofilamentstiffer

Goodknotsbothmaterials

Moredragwithbraid

Bothhightensilestrength

Mono~36days,Braid~30days

Minimalbothmaterials

Excellentbothmaterials

NoSSDinCTchangesbetween2

groupsat8/12 SmallWRshiftinXstitchgroup

 

 

 

 

Phaco (superior, 4 mm × 3 mm 10/0 – 47 eyes UCVA

Mendivil, RCT

Astigmatism

 

 

 

VA

49eyes

 

 

 

–50eyes

9/0–

 

 

 

Nylon

posteriortosurgicallimbusscleral

tunnel)closure1suture:

10/0Ethilonmonofilamentv

9/0Ethilonmonofilament Nocautery Tightnesscontrolled

Phaco(6·5/7·5mmscleraltunnel,

FU1,2weeks

and6,

12months

 

RCT

56

 

 

 

Gimbel

1997

 

 

 

Prolene – 52 eyes SIA

superior closure:incision)

FU 2–31/7,

.,al et

Visualrehab

 

 

 

Mersilene–

48eyes

Novafil–50eyes

 

10/0nylonmonofilamentv

10/0Prolenev

11/0Mersilenev

10/0Novafil Lightcautery,continuousshoelace closure

wks,

2/3/6/12/

24months

 

38

 

 

 

1992

 

 

 

Pliability

Phaco (2 sutures – 1 mono,1 braid) 150 eyes

Blaydes RCT

and Berry, FU 24 hrs, ICCE/ECCE (9 sutures – 2 mono, 9/0 mono and Knot

Pull-through

Strength

Disappearance Reaction Wound healing

CT

 

9/0braidinall

 

 

Radial–25eyes

Xstitch–25eyes

2braidpoly910and510/0nylon)

9/0Monofilamentpolyglactin910

versus9/0Braidpolyglactin910

Phaco(5mmclearcornealincision,

temporal,1suture10/0vicryl,

1,2,3,4,5wks

 

 

RCT

FU8/12

1979

 

 

Holweger

and

57

 

 

 

 

PMMA lens):

Marefat,

Radial stitch versus X stitch

46 1997

ICCE, intracapsular extraction, ECCE, extracapsular cataract extraction via nuclear expression and intraocular lens implant; Phaco, phacoemulsification and intraocular lens implant; UCVA, uncorrected visual acuity; BCVA, best corrected visual acuity; SSD, statistical significant difference; SIA, surgically induced astigmatism; Ethilon, monofilament nylon polyamide-6; polyglactin 910 (vicryl), copolymer of lactide and glycolide; Prolene, polypropylene; Mersilene, polyester; Novafil, polyethylene; AR, against the rule astigmatism; WR, with the rule astigmatism; CT, corneal topography

Notes

 

Results

 

Outcomes

materials

Participants

phacoincisionclosurebyalternative

Intervention

Effecton

Methods

Table32.10

Authors

Onesurgeon

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NoSSDbetweensutureandadhesive

groups

Statsigmoreastigmatisminwithout

suturegroupthanothersat1/52,

<(P0·1)noSSDat12/52

SIAsmallerinfibringroupat6/12FU

<(P0·05)

NoSSDinBCVAbetweengroups

Statsiglessastigmatisminfibrin

<group(P0·05)

 

Statsigbetterconjwoundclosurein

salineinjectedgroupupto7daysFU

NoSSDat28days

 

 

 

 

 

 

 

 

 

Astigmatism

 

 

 

 

Astigmatism

VA

 

Astigmatism

 

 

Baresclera

 

 

 

Withsuture–

105eyes

withoutsuture–

101eyes

Adhesive– 103eyes

Fibrin–167eyes

Stitch–218eyes

 

Fibrin–28eyes

Stitch–28eyes

 

Manually–

22eyes

Salineinjection–

16eyes

6·5mm×2·5mmpostlimbusscleral

tunnel,frownincisionclosure:

×withsuture(110/0nylon)v withoutsuturev cyanoacrylateadhesive

6mm×2·5mmpostlimbusscleral

tunnelclosure:

Tissucol(fibrin)v singlestitch(10/0nylon)

6mm×2mmpostlimbusscleral

tunnelclosure:

Tissucol(fibrin)v singlestitch(10/0nylon)

5mmscleraltunnel

conjunctivalclosure:

manuallyv salineinjection

RCT

FU1,12/52

 

 

 

RCT FU1,7days

6months

RCT

etal.,

1997

RCT

FU1,7,

28days

1996

Alióetal.,

1996

 

 

 

Mester

etal.,

1993

Mulet

 

Meacock

etal.,

 

50

 

 

 

 

 

58

 

 

59

 

 

 

60

Phaco, phacoemulsification and intraocular lens implant; UCVA, uncorrected visual acuity; BCVA, best corrected visual acuity; SSD, statistical significant difference;

2 thrombin/CaCland

protein/apoproteincomponents

surgicallySIA, astigmatism;induced fibrinTissucol, 2sealant

Cataract surgical techniques

References

1.Laurell CG, Zetterström C, Philipson B et al. Randomized study of the blood–aqueous barrier reaction after phacoemulsification and extracapsular cataract extraction. Acta Ophthalmol Scand 1998;76: 573–8.

2.Dowler JG, Hykin PG, Hamilton AM. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes.

Ophthalmology 2000;107:457–62.

3.Chee SP, Ti SE, Sivakumar M et al. Postoperative Inflammation:

extracapsular cataract extraction versus phacoemulsification.

JCataract Refractive Surg 1999;25:1280–5.

4.Landau IE, Laurell C-G. Ultrasound biomicroscopy examination of intraocular lens haptic position after phacoemulsification with continuous curvilinear capsulorhexis and extracapsular cataract extraction with linear capsulotomy. Acta Ophthalmol Scand 1999; 77:394–6.

5.Ravalico G, Tognetto D, Palomba MA et al. Corneal endothelial function after extracapsular cataract extraction and phacoemulsification.

JCataract Refractive Surg 1997;23:1000–5.

6.Leen MM, Ho CC, Yanoff M. Association between surgically-induced astigmatism and cataract incision size in the early postoperative period. Ophthalmic Surg 1993;24:586–92.

7.Minassian DC, Rosen P, Dart JKG et al. Extracapsular cataract extraction compared with small incision surgery by phacoemulsification: a randomized trial. Br J Ophthalmol 2001;85: 822–9.

8.Jürgens I, Matheu A, Castilla M. Ocular hypertension after cataract surgery: a comparison of three surgical techniques and two viscoelastics. Ophthalmic Surg Lasers 1997;28:30–6.

9.Bömer TG, Lagreze WD, Funk J. Intraocular Pressure Rise after Cataract Extraction – Influence of Surgical Technique, Surgeon’s Experience and Prophylactic Medication. A Prospective, Randomized Double-Blind Study. Klinische Monatsblatter Für Augenheilkunde

1995;206:13–9.

10.Lüchtenberg M, Luchtenberg C, Lang M et al. Intraocular pressure after IOL implantation by using three different types of viscoelastics.

Ophthalmology 2000;97:331–5.

11.Smith SG, Lindstrom RL. 2% Hydroxypropyl methylcellulose as a viscous surgical adjunct. A multicenter prospective randomized trial.

JCataract Refractive Surg 1991;17:839–42.

12.Pedersen OO. Comparison of the protective effects of methylcellulose and sodium hyaluronate on corneal swelling following phacoemulsification of senile cataracts. J Cataract Refractive Surg 1990;16:594–6.

13.Probst LE, Nichols BD. Corneal endothelial and intraocular pressure changes after phacoemulsification with Amvisc Plus and Viscoat. J Cataract Refractive Surg 1993;19:725–30.

14.Rainer G, Menapace R, Findl O et al. Intraocular pressure after small incision cataract surgery with Healon 5 and Viscoat. J Cataract Refractive Surg 2000;26:271–6.

15.Miller KM, Colvard DM. Randomized clinical comparison of Healon GV and Viscoat. J Cataract Refractive Surg 1999;25:1630–6.

16.Koch DD, Liu JF, Glasser DB et al. A comparison of corneal endothelial changes after use of Healon or Viscoat during phacoemulsification. Am J Ophthalmol 1993;115:188–201.

17.Kohnen T, von Ehr M, Schutte E et al. Evaluation of intraocular pressure with Healon and Healon GV in sutureless cataract surgery with foldable lens implantation. J Cataract Refractive Surg 1996;22: 227–37.

18.Arshinoff SA, Hofmann I. Prospective, randomized trial of Microvisc and Healon in routine phacoemulsification. J Cataract Refractive Surg 1997;23:761–5.

19.John ME, Randall LN, Boleyn BA et al. Effect of a superficial and a deep scleral pocket incision on the incidence of hyphema. J Cataract Refractive Surg 1992;18:495–9.

20.Anders N, Pham DT, Wollensak J. Wound Strength in self-sealing cataract surgery depending on the site and the depth of the Incision.

Klinische Monatsblatter Für Augenheilkunde 1995;206:442–5.

21.Dick HB, Schwenn O, Krummenauer F et al. Inflammation after sclerocorneal versus clear corneal tunnel phacoemulsification.

Ophthalmology 2000;107:241–7.

22.Kurimoto Y, Komurasaki Y, Yoshimura N et al. Corneal astigmatism After cataract surgery with 4·1 mm BENT scleral and 4·1 mm plus meridian corneal incisions. J Cataract Refractive Surg 1999;25: 427–31.

23.Cillino S, Morreale D, Mauceri A et al. Temporal versus superior approach phacoemulsification: Short-term postoperative astigmatism.

J Cataract Refractive Surg 1997;23:267–71.

24.Olsen T, Dam Johansen M, Bek T et al. Corneal versus scleral tunnel incision in cataract surgery: a randomized study. J Cataract Refractive Surg 1997;23:337–41.

25.Hunold W, Auffarth GU, Bailitis S et al. No-stitch tunnel incision versus corneoscleral incision. A prospective, randomized study.

Ophthalmology 1995;92:274–9.

26.Gimbel HV, Sun R, DeBroff BM. Effects of wound architecture and suture technique on postoperative astigmatism. Ophthalmic Surg Lasers 1995;26:524–8.

27.Anders N, Pham DT, Antoni HJ et al. Postoperative astigmatism and relative strength of tunnel incisions: a prospective clinical trial. J Cataract Refractive Surg 1997;23:332–6.

28.Bömer TG, Lagreze WD, Funk J. Intraocular pressure rise after phacoemulsification with posterior chamber lens implantation: effect of prophylactic medication, wound closure, and surgeon’s experience. Br J Ophthalmol 1995;79(9):809–13.

29.Kawano K. Modified corneoscleral incision to reduce postoperative

astigmatism after 6 mm diameter intraocular lens implantation.

J Cataract Refractive Surg 1993;19:387–92.

30.Wirbelauer C, Anders N, Pham DT et al. Effect of incision location on

preoperative oblique astigmatism after scleral tunnel incision.

J Cataract Refractive Surg 1997;23:365–71.

31.Mendivil A. Comparative study of astigmatism through superior and lateral small incisions. Eur J Ophthalmol 1996;6:389–92.

32.El Maghraby A, Anwar M, el Sayyad F et al. Effect of incision size on

early postoperative visual rehabilitation after cataract surgery and intraocular lens implantation. J Cataract Refractive Surg 1993; 19:494–8.

33.Grabow HB. Early Results of 500 Cases of No-Stitch cataract surgery.

J Cataract Refractive Surg 1991;17(Suppl):726–30.

34.Martin RG, Sanders DR, Miller JD et al. Effect of cataract wound incision size on acute changes in corneal topography. J Cataract Refractive Surg 1993;19(Suppl):170–7.

35.Olson RJ, Crandall AS. Prospective randomized comparison of phacoemulsification cataract surgery with a 3·2-mm v a 5·5-mm sutureless incision. Am J Ophthalmol 1998;125:612–20.

36.Levy JH, Pisacano MD, Chadwick BS. Astigmatic changes after cataract surgery with 5·1 mm and 3·5 mm sutureless incisions. J Cataract Refractive Surg 1994;20:630–3.

37.Mendivil A. Intraocular lens implantation through 3·2 versus 4·0 mm incisions. J Cataract Refractive Surg 1996;22:1461–4.

38.Gimbel HV, Raanan DG, DeLuca M. Effect of suture material on postoperative astigmatism. J Cataract Refractive Surg 1992;18:42–50.

39.Dam-Johansen M, Olsen T. Induced astigmatism after 4 and 6 mm scleral tunnel incision. A randomized study. Acta Ophthalmo Scand 1997;75:669–74.

40.Davison JA. Keratometric comparison of 4·0 mm and 5·5 mm scleral tunnel cataract incisions. J Cataract Refrac Surg 1993;19:3–8.

41.Oshika T, Tsuboi S, Yaguchi S et al. Comparative study of intraocular lens implantation through 3·2 and 5·5 mm incisions. Ophthalmology 1994;101(7):1183–90.

42.Hayashi K, Hayashi H, Nakao F et al. The correlation between incision size and corneal shape changes in sutureless cataract surgery.

Ophthalmology 1995;102:550–6.

43.Diestelhorst M, Dinslage S, Konen W et al. Effect of 3·0 mm tunnel and 6·0 mm corneoscleral incisions on the blood–aqueous barrier.

J Cataract Refractive Surg 1996;22:1465–70.

44.Kohnen T, Dick B, Jacobi KW. Comparison of the induced astigmatism after temporal clear corneal tunnel incisions of different sizes. J Cataract Refractive Surg 1995;21:417–24.

241

Evidence-based Ophthalmology

45.Dick HB, Kohnen T, Jacobi FK, Jacobi KW. Long-term endothelial cell loss following phacoemulsification through a temporal clear corneal incision. J Cataract Refractive Surg 1996;22:63–71.

46.Holweger RR, Marefat B. Corneal changes after cataract surgery with 5·0 mm sutured and 3·5 mm sutureless clear corneal incisions. J Cataract Refractive Surg 1997;23:342–6.

47.Kosrirukvongs P, Slade SG, Berkeley RG. Corneal endothelial changes after divide and conquer versus chip and flip phacoemulsification.

J Cataract Refractive Surg 1997;23:1006–12.

48.Kohlhaas M, Klemm M, Kammann J et al. Endothelial cell loss after phacoemulsification – a comparison between the “Reversed Tip and Snip” technique and “Divide and Conquer” technique. Klinische Monatsblatter Für Augenheilkunde 1997;210(2):82–5.

49.Wong T, Hingorani M, Lee V. Phacoemulsification time and power requirements in phaco chop and divide and conquer nucleofractis techniques. J Cataract Refractive Surg 2000;26:1374–8.

50.Alio J L, Mulet ME, Garcia JC. Use of cyanoacrylate tissue adhesive in small-incision cataract surgery. Ophthalmic Surg Lasers 1996; 27:270–4.

51.Mendivil A. Frequency of induced astigmatism following phacoemulsification with suturing versus without suturing.

Ophthalmic Surg Lasers 1997;28(5):377–81.

52.Lyhne N, Corydon L. Astigmatism after phacoemulsification with adjusted and unadjusted sutured versus sutureless 5·2 mm superior scleral incisions. J Cataract Refractive Surg 1996;22:1206–10.

53.El Kasaby HT, McDonnell PJ, Deutsch J. Videokeratography: a comparison between 6 mm sutured and unsutured incisions for phacoemulsification. Eye 1995;9:719–21.

54.Lyhne N, Corydon, L. Two year follow up of astigmatism after

phacoemulsification with adjusted and unadjusted sutured versus sutureless 5·2 mm superior scleral incisions. J Cataract Refract Surg 1998;24:1647–51.

55.Azar DT, Stark WJ, Dodick J et al. Prospective, randomized vector analysis of astigmatism after three-, one-, and no-suture phacoemulsification. J Cataract Refractive Surg 1997;23:1164–73.

56.Mendivil A. Effect of nylon suture diameter on induced astigmatism after phacoemulsification. J Cataract Refract Surg 1997;23: 1196–9.

57.Blaydes JE, Berry J. A comparative evaluation of 9-0 monofilament and 9-0 braid polyglactin 910 in cataract surgery (intracapsular, extracapsular, and phacoemulsification). Ophthalmic Surg 1979;10:49–54.

58.Mester U, Zuche M, Rauber M. astigmatism after phacoemulsification with posterior chamber lens implantation: small incision technique with fibrin adhesive for wound closure. J Cataract Refractive Surg 1993;19:616–9.

59.Mulet Homs ME, Alio Y, Sanz JL et al. Efficacy of fibrinogen as bioadhesive in cataract surgery through scleral tunnel. Archivos De La Sociedad Espanola De Oftalmologia 1997;72:427–30.

60.Meacock WR, Chittenden H, Govan J. Conjunctival wound closure by saline injection in sutureless, scleral tunnel incision phacoemulsification. J Cataract Refractive Surg 1996;22:1240–1.

242